
Tissue Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Description
Tissue Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Tissue Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Tissue Heart Valves pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Tissue heart valve are a combination of tissue and synthetic biomaterials with the tissue itself being flexible. Bovine and porcine valves are included here.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Tissue Heart Valves under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Tissue Heart Valves and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Tissue Heart Valves under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
78 Pages
- About GlobalData
- Tissue Heart Valves Overview
- Tissue Heart Valves - Pipeline Products by Stage of Development
- Tissue Heart Valves - Pipeline Products by Segment
- Tissue Heart Valves - Pipeline Products by Territory
- Tissue Heart Valves - Pipeline Products by Regulatory Path
- Tissue Heart Valves - Pipeline Products by Estimated Approval Date
- Tissue Heart Valves - Ongoing Clinical Trials
- Tissue Heart Valves Companies - Pipeline Products by Stage of Development
- Tissue Heart Valves - Companies Pipeline Products by Stage of Development
- AGEless Biomedical Inc Company Overview
- Anchorvalve Company Overview
- Artivion Inc Company Overview
- AutoTissue Berlin GmbH Company Overview
- Boston Children's Hospital Company Overview
- Colibri Heart Valve LLC Company Overview
- Collplant Biotechnologies Ltd Company Overview
- CorMatrix Cardiovascular Inc Company Overview
- CroiValve Ltd Company Overview
- Cytograft Tissue Engineering Inc (Inactive) Company Overview
- Daidalos Solutions BV Company Overview
- Edwards Lifesciences Corp Company Overview
- enVVeno Medical Corp Company Overview
- Haimai Medical Technology Co Ltd Company Overview
- Harvard Apparatus Regenerative Technology Inc Company Overview
- Medtronic Plc Company Overview
- Meril Life Sciences Pvt Ltd Company Overview
- National University of Singapore Company Overview
- Neoolife Inc Company Overview
- Revivicor Inc Company Overview
- Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
- Stellenbosch University Company Overview
- The Charles Stark Draper Laboratory Inc Company Overview
- University of California Irvine Company Overview
- University of Cambridge Company Overview
- University of Zurich Company Overview
- ValveXchange, Inc. (Inactive) Company Overview
- Venus Haoyue Medtech Ltd Company Overview
- Venus Medtech Hangzhou Inc Company Overview
- Verigraft AB Company Overview
- VueKlar Cardiovascular Ltd (Inactive) Company Overview
- W. L. Gore & Associates Inc Company Overview
- Apr 15, 2024: Edwards Lifesciences Appoints New China Head
- Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
- Mar 04, 2024: LivaNova to Present at the Barclays Global Healthcare Conference
- Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
- Feb 05, 2024: LivaNova Picks Longtime J&J Exec as New CEO
- Jan 25, 2024: CroiValve Announces FDA IDE Approval and Initiation of its Early Feasibility Study
- Oct 27, 2023: Edwards receives CE Mark for MITRIS RESILIA valve
- Oct 19, 2023: Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results
- Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
- Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
- Sep 21, 2023: LivaNova Announces Marco Dolci, President of Cardiopulmonary, to Retire at the End of 2023
- Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
- Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
- Aug 21, 2023: Tissue Regenix Group Notice of Interim Results
- Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
- May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
- May 07, 2023: Edwards' Aortic valve with Resilia tissue shows favorable durability, safety and efficacy outcomes in seven year data
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.